Mohawk Industries 第三季度业绩报告
佐治亚州卡尔霍恩, Oct. 26, 2024 (GLOBE NEWSWIRE) -- Mohawk Industries, Inc. (纽约证券交易所交易代码：MHK) 今日宣布 2024 年第三季度净收益 1.62 亿美元，每股收益(“EPS”) 2.55 美元；调整后净收益 1.84 亿美元，调整后每股收益为 2.90 美元。 2024 年第三季度净销售额 27 亿美元，据报告同比下降 1.7%，调整后同比下降 2.1%。 2023 年第三季度，公司报告净销售额为…
ROCKWOOL renforce sa position sur le marché britannique avec l’acquisition de Wetherby Building Systems Ltd.
LONDRES, 27 oct. 2024 (GLOBE NEWSWIRE) -- Le groupe ROCKWOOL, basé au Danemark, est heureux d’annoncer l’acquisition de Wetherby Building Systems Ltd. Cette acquisition représente une étape importante pour ROCKWOOL…
Travere Therapeutics Presents Data Reinforcing Clinical Benefit of FILSPARI® (Sparsentan) in IgAN and Late-Breaking Presentation in FSGS at ASN Kidney Week 2024
Nearly 60% of patients with IgAN in the SPARTAN Study achieved complete remission when using FILSPARI as first-line treatment SPARTACUS Study, PROTECT open-label extension, and real-world evidence presentations highlight initial…
ROCKWOOL stärkt seine Position auf dem britischen Markt durch Übernahme von Wetherby Building Systems Ltd.
LONDON, Oct. 27, 2024 (GLOBE NEWSWIRE) -- Die dänische ROCKWOOL-Gruppe freut sich, die Übernahme von Wetherby Building Systems Ltd. bekanntzugeben. Die Übernahme ist ein wichtiger Meilenstein im Bestreben von ROCKWOOL,…
Empty Capsules Market to Grow at USD 4.96 Billion by 2031 |SkyQuest Technology
Westford, USA, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Empty Capsules Market size was valued at USD 2.89 billion in 2023 to USD 4.96 billion by 2031, growing at a CAGR…
Circuit Breaker Market to Exceed Market Valuation USD 9.4 Billion by 2031
Westford USA, Oct. 25, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the global circuit breaker market will reach a value of USD 9.4 Billion by 2031, with a CAGR of…
Trinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCapture
DUBLIN, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced the…
Pivotal VALIANT Results Presented at Kidney Week Highlight Strength of Pegcetacoplan Treatment Effect in Patients with C3G
Statistically significant 68% (p
Celldex Announces Barzolvolimab Met All Primary and Secondary Endpoints with High Statistical Significance in Positive Phase 2 Study in Chronic Inducible Urticaria
First to demonstrate clinical benefit in patients with chronic inducible urticaria (CIndU) in large, randomized, placebo-controlled study Favorable safety and tolerability Plan to advance CIndU into Phase 3 developmentCompany to…
Vera Therapeutics Announces 96-week eGFR Stabilization in ORIGIN Phase 2b Study of Atacicept in IgAN in a Late-Breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024
Long-term improvements observed in the quartet of findings defining disease modification supports atacicept’s potential to prevent kidney failure in patients with IgAN;Long-term results from the ORIGIN Phase 2b study were…